Table 2.
Univariate and multivariate Cox regression analyses of the prognostic variables in ESCC patients
| Variables | Subsets | Univariate analysis (n = 79) | Multivariate analysis (n = 79) | ||||
|---|---|---|---|---|---|---|---|
| Hazard ratio | 95% CI | P | Hazard ratio | 95% CI | P | ||
| Age | ≤ 60 vs. >60 | 1.779 | 0.628–5.042 | 0.278 | – | – | – |
| Gender | Male vs. Female | 0.601 | 0.212–1.703 | 0.338 | – | – | – |
| T-stage | T1 + T2 vs. T3 + T4 | 0.875 | 0.252–3.037 | 0.834 | – | – | – |
| N-stage | No vs. Yes | 3.169 | 1.175–8.545 | 0.023 | 12.292 | 1.399–108.003 | 0.024 |
| Histological grade | G1 vs. G2–G3 | 2.470 | 0.920–6.631 | 0.073 | – | – | – |
| Clinical stage | I–II vs. III–IV | 0.407 | 0.150–1.104 | 0.077 | – | – | – |
| IgG (EU) | ≤ 2760 vs. >2760 | 3.039 | 1.148–8.041 | 0.025 | 4.910 | 1.473–16.364 | 0.010 |
| IgA (EU) | ≤ 1130 vs. >1130 | 3.588 | 1.368–9.409 | 0.009 | 4.686 | 1.492–14.722 | 0.008 |